The cost of the government’s drug pricing deal with the Trump administration will come out of the NHS budget instead of the Treasury’s and could eventually reach £9bn a year, campaigners fear.
Patrick Vallance, the science minister, has confirmed that the costs – initially an extra £1bn over three years– will be borne by the Department of Health and Social Care, which funds the NHS in England, and not the Treasury.
His admission, in a letter to the Commons science, innovation and technology committee, is the first time the government has spec
Continue Reading on The Guardian
This preview shows approximately 15% of the article. Read the full story on the publisher's website to support quality journalism.